๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Assessment of the Safety and Efficacy of Biologic Monotherapy Versus Combination Biologic and Immunosuppressant Therapy for the Treatment of Inflammatory Bowel Disease

โœ Scribed by Wheat, Chelle ;Lynema, Stacey ;Ko, Cynthia W. ;Etter, Scott ;Cullinan, Cory ;Sinanan, Mika N. ;Lee, Scott D.

Book ID
122441083
Publisher
Elsevier Science
Year
2011
Tongue
English
Weight
66 KB
Volume
140
Category
Article
ISSN
0016-5085

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Biologic therapy in the management of ex
Biologic therapy in the management of extraintestinal manifestations of inflammatory bowel disease
โœ Arthur Barrie; Miguel Regueiro ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 91 KB ๐Ÿ‘ 2 views

The inflammatory bowel diseases (IBD), notably Crohn's disease (CD) and ulcerative colitis (UC), are systemic inflammatory diseases primarily involving the gastrointestinal tract. Twenty percent to 40% of patients with IBD develop extraintestinal inflammation and symptoms, known as extraintestinal m

Safety of immunomodulators and biologics
Safety of immunomodulators and biologics for the treatment of inflammatory bowel disease during pregnancy and breast-feeding
โœ Javier P. Gisbert ๐Ÿ“‚ Article ๐Ÿ“… 2010 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 154 KB ๐Ÿ‘ 2 views

The aim of this article is to critically review available data regarding the safety of immunomodulators and biological therapies during pregnancy and breast-feeding in women with inflammatory bowel disease. Methotrexate and thalidomide can cause congenital anomalies and are contraindicated during pr